ARA-290
58
Vendors
169
Samples
6.6
Average score
23 May 2026
Latest assay
| № | Vendor | Rating | Samples | Avg | Min | Max | Most recent |
|---|---|---|---|---|---|---|---|
| 1 | Homopeptide | A | 6 | 10.0 | 9.9 | 10.0 | 24 May 2026 |
| 2 | Bachem | A | 4 | 10.0 | 10.0 | 10.0 | 28 Jun 2026 |
| 3 | Hubei Jianxiang | A | 4 | 10.0 | 10.0 | 10.0 | 7 Jul 2026 |
| 4 | Shanghai Wibson Biotechnology | A | 4 | 10.0 | 9.9 | 10.0 | 27 Jun 2026 |
| 5 | GenScript Peptides | A | 4 | 10.0 | 10.0 | 10.0 | 18 Aug 2026 |
| 6 | Sigma-Aldrich | A | 4 | 10.0 | 9.9 | 10.0 | 22 Jul 2026 |
| 7 | Sangon Bio | A | 3 | 10.0 | 10.0 | 10.0 | 25 Apr 2026 |
| 8 | Kerui Peptides | A | 3 | 10.0 | 9.9 | 10.0 | 17 May 2026 |
| 9 | Flourishglobal Peptide | A | 3 | 10.0 | 9.9 | 10.0 | 24 Jun 2026 |
| 10 | WuXi TIDES | A | 3 | 10.0 | 9.9 | 10.0 | 23 Apr 2026 |
| 11 | Hybio Pharmaceutical | A | 3 | 10.0 | 9.9 | 10.0 | 10 Jul 2026 |
| 12 | Shanghai ERP Biotechnology | A | 2 | 10.0 | 10.0 | 10.0 | 9 Apr 2026 |
| 13 | JEEP Peptides | A | 2 | 10.0 | 10.0 | 10.0 | 1 Jul 2026 |
| 14 | Mokemei Biotechnology | A | 2 | 10.0 | 10.0 | 10.0 | 13 May 2026 |
| 15 | Chinese Peptide Company | A | 2 | 10.0 | 10.0 | 10.0 | 24 May 2026 |
| 16 | PolyPeptide Group | A | 2 | 10.0 | 10.0 | 10.0 | 8 Mar 2026 |
| 17 | Tianjin Finder Chemical TFC | A | 7 | 9.9 | 9.9 | 10.0 | 16 Apr 2026 |
| 18 | Shanghai Sigma Audley | A | 4 | 9.9 | 9.9 | 10.0 | 17 Jul 2026 |
| 19 | Thermo Fisher Scientific | A | 4 | 9.9 | 9.9 | 10.0 | 23 Jul 2026 |
| 20 | Asymchem | A | 4 | 9.9 | 9.9 | 10.0 | 5 Jul 2026 |
| 21 | QYAOBIO | A | 3 | 9.9 | 9.9 | 10.0 | 8 Jul 2026 |
| 22 | AmbioPharm | A | 3 | 9.9 | 9.9 | 10.0 | 19 May 2026 |
| 23 | SinoPep | A | 2 | 9.9 | 9.9 | 9.9 | 16 Aug 2026 |
| 24 | Shanghai Sigma Audley SSA | A | 2 | 8.8 | 7.7 | 9.9 | 24 May 2026 |
| 25 | Qingdao Sigma Chemical QSC | A | 5 | 8.6 | 6.8 | 9.9 | 21 May 2026 |
| 26 | Nantong Guangyuan Chemical GYC | A | 2 | 8.2 | 8.0 | 8.4 | 21 May 2026 |
| 27 | Wuhan Wansheng Bio (WWB) | A | 4 | 7.8 | 6.0 | 8.9 | 23 May 2026 |
| 28 | Glbiochem (Shanghai) | A | 5 | 7.5 | 6.0 | 8.5 | 24 May 2026 |
| 29 | Heman Peptide HM | A | 2 | 8.7 | 8.2 | 9.2 | 21 May 2026 |
| 30 | Nuscience Peptides | A | 3 | 8.4 | 7.3 | 9.6 | 23 May 2026 |
| 31 | Yiwu Aozuo Trading Co | A | 5 | 8.2 | 6.3 | 10.0 | 24 May 2026 |
| 32 | Injectify | A | 2 | 8.2 | 7.5 | 9.0 | 26 Jan 2026 |
| 33 | Skye Peptides | A | 6 | 8.0 | 5.3 | 10.0 | 20 May 2026 |
| 34 | Peptronix Bio PTB | X | 1 | 8.0 | 8.0 | 8.0 | 21 May 2025 |
| 35 | Hunan Ruiwang Technology Center | X | 1 | 8.0 | 8.0 | 8.0 | 13 Feb 2025 |
| 36 | Eternal Peptides | A | 2 | 7.9 | 6.9 | 8.8 | 17 May 2026 |
| 37 | Shanghai Baoju | B | 2 | 7.7 | 7.4 | 8.0 | 24 May 2026 |
| 38 | Nanjing Xiyuxun Technology XYX | X | 1 | 7.6 | 7.6 | 7.6 | 6 May 2025 |
| 39 | Bfflist AMO | B | 2 | 7.5 | 7.4 | 7.6 | 21 May 2026 |
| 40 | Peptide Partners | A | 2 | 7.2 | 6.9 | 7.5 | 21 May 2026 |
| 41 | Peptide-S | A | 11 | 7.1 | 5.6 | 9.4 | 23 May 2026 |
| 42 | Peptidology | X | 1 | 6.9 | 6.9 | 6.9 | 11 Jun 2025 |
| 43 | Peptide Haven | X | 1 | 6.9 | 6.9 | 6.9 | 3 Jun 2025 |
| 44 | Oupeptide | A | 10 | 6.7 | 4.4 | 8.5 | 24 May 2026 |
| 45 | Precision Peptide Co | X | 1 | 6.3 | 6.3 | 6.3 | 3 Jul 2025 |
| 46 | Zhang TY | X | 1 | 5.9 | 5.9 | 5.9 | 11 Jun 2025 |
| 47 | HXNet | C | 4 | 5.7 | 3.4 | 7.4 | 20 May 2026 |
| 48 | Platinum Cryo | X | 1 | 5.7 | 5.7 | 5.7 | 24 Apr 2025 |
| 49 | Elite Research USA | B | 3 | 5.6 | 5.1 | 5.9 | 24 May 2026 |
| 50 | WllyBIO | X | 1 | 5.4 | 5.4 | 5.4 | 3 Jun 2025 |
| 51 | Haikou Mingheng Technology | X | 1 | 4.9 | 4.9 | 4.9 | 7 May 2025 |
| 52 | ZhuoYan lab | C | 3 | 4.7 | 4.3 | 5.1 | 19 Jan 2026 |
| 53 | Amino Amigos | X | 1 | 3.0 | 3.0 | 3.0 | 24 Apr 2025 |
| 54 | NuLife Peptides | X | 1 | 2.3 | 2.3 | 2.3 | 13 Jun 2025 |
| 55 | Qingdao VitaConin International Trading | X | 1 | 2.1 | 2.1 | 2.1 | 2 Jul 2025 |
| 56 | Hebei Chengtong Technology | X | 1 | 0.0 | 0.0 | 0.0 | 21 May 2025 |
| 57 | Coffee and Peppers | X | 1 | 0.0 | 0.0 | 0.0 | 7 May 2025 |
| 58 | Advanced Technology and Industrial | X | 1 | 0.0 | 0.0 | 0.0 | 25 Apr 2025 |